Literature DB >> 18551299

Pituitary blastoma.

Bernd W Scheithauer1, Kalman Kovacs, Eva Horvath, D S Kim, Robert Y Osamura, Rhett P Ketterling, Ricardo V Lloyd, O L Kim.   

Abstract

A 13-month-old Korean female presented with Cushing disease and diabetes insipidus. On MRI, a 3.5-cm, focally cystic, contrast-enhancing, sellar and suprasellar mass was noted. Aside from blood adrenocorticotropin (ACTH) and cortisol elevation, other pituitary hormone blood levels were normal or markedly reduced. The subtotally resected lesion consisted of synaptophysin-immunoreactive lobules of (a) large, polygonal, amphophilic, PAS-positive cells immunoreactive for ACTH, beta-endorphin, alpha melanocyte stimulating hormone (MSH), and keratin (CAM5.2) in some cells showing Crooke hyaline change, (b) less frequent acidophilic, growth hormone (GH) immunoreactive cells, and (c) rare luteinizing hormone (LH) and/or alpha subunit immunopositive cells. Also conspicuous were smaller cells resembling Rathke-type epithelium forming rosettes to sizable glands immunoreactive for EMA, keratin, S-100 protein, galectin-3 and rarely for synaptophysin and/or one of the above-noted adenohypophysial hormones. Transcription factors, including Neuro-D1 and Pit-1, were present in ACTH- and GH-producing cells, respectively, but only in occasional Rathke-type cells. The MIB-1 labeling index (LI) was 1.5% in secretory cells and 39% in Rathke-type epithelium. Ultrastructurally, the tissue resembled fetal pituitary of 10-12 weeks gestation and contained fully differentiated corticotrophs and somatotrophs, scant cells of glycoprotein-hormone producing type with small secretory granules, and glandular epithelial cells consistent with committed, but largely undifferentiated Rathke-type epithelium. We consider the tumor as a pituitary blastoma, a lesion composed of multiple cell types common to the development of the affected organ based upon (a) prominence of primitive Rathke-type epithelium, (b) disposition of secretory cells in lobules rather than acini, (c) the limited range of secretory cells represented, (d) the presence of their corresponding transcription factors, and (e) ultrastructural features indicating orderly development of the 10- to 12-week embryonic stage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18551299     DOI: 10.1007/s00401-008-0388-9

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  18 in total

Review 1.  Pediatric sellar and suprasellar lesions.

Authors:  Jason W Schroeder; L Gilbert Vezina
Journal:  Pediatr Radiol       Date:  2011-01-26

2.  Teratoma of the Sellar Region: a Case Report.

Authors:  Wolfgang Saeger; Azadeh Ebrahimi; Rudi Beschorner; Hildegard Spital; Jürgen Honegger; Waldemar Wilczak
Journal:  Endocr Pathol       Date:  2017-12       Impact factor: 3.943

Review 3.  Genomics and Epigenomics of Pituitary Tumors: What Do Pathologists Need to Know?

Authors:  Sylvia L Asa; Ozgur Mete; Shereen Ezzat
Journal:  Endocr Pathol       Date:  2021-01-12       Impact factor: 3.943

4.  Pituitary blastoma: a unique embryonal tumor.

Authors:  Bernd W Scheithauer; E Horvath; T W Abel; Y Robital; S-H Park; R Y Osamura; C Deal; R V Lloyd; K Kovacs
Journal:  Pituitary       Date:  2012-09       Impact factor: 4.107

Review 5.  MicroRNAs: Suggested role in pituitary adenoma pathogenesis.

Authors:  M R Gadelha; L Kasuki; J Dénes; G Trivellin; M Korbonits
Journal:  J Endocrinol Invest       Date:  2013-11       Impact factor: 4.256

Review 6.  Genetics of Cushing's Syndrome.

Authors:  Laura C Hernández-Ramírez; Constantine A Stratakis
Journal:  Endocrinol Metab Clin North Am       Date:  2018-06       Impact factor: 4.741

Review 7.  DICER1: mutations, microRNAs and mechanisms.

Authors:  William D Foulkes; John R Priest; Thomas F Duchaine
Journal:  Nat Rev Cancer       Date:  2014-09-01       Impact factor: 60.716

Review 8.  Overview of the 2017 WHO Classification of Pituitary Tumors.

Authors:  Ozgur Mete; M Beatriz Lopes
Journal:  Endocr Pathol       Date:  2017-09       Impact factor: 3.943

9.  Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations.

Authors:  Leanne de Kock; Nelly Sabbaghian; François Plourde; Archana Srivastava; Evan Weber; Dorothée Bouron-Dal Soglio; Nancy Hamel; Joon Hyuk Choi; Sung-Hye Park; Cheri L Deal; Megan M Kelsey; Megan K Dishop; Adam Esbenshade; John F Kuttesch; Thomas S Jacques; Arie Perry; Heinz Leichter; Philippe Maeder; Marie-Anne Brundler; Justin Warner; James Neal; Margaret Zacharin; Márta Korbonits; Trevor Cole; Heidi Traunecker; Thomas W McLean; Fabio Rotondo; Pierre Lepage; Steffen Albrecht; Eva Horvath; Kalman Kovacs; John R Priest; William D Foulkes
Journal:  Acta Neuropathol       Date:  2014-05-20       Impact factor: 17.088

Review 10.  Imaging of DICER1 syndrome.

Authors:  R Paul Guillerman; William D Foulkes; John R Priest
Journal:  Pediatr Radiol       Date:  2019-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.